InnovaRx Innova Health Strategies

F18.97

Inhalant use, unspecified with inhalant-induced persisting dementia

Billable FY2026 2025-10-01 → 2026-09-30
This is the unspecified option. 7 more specific codes sit alongside it. Worth checking whether the documentation supports one of them.
Exclusions 3 never code together
F18.9code
Excludes1
  • inhalant abuse (F18.1-)F18.1-
  • inhalant dependence (F18.2-)F18.2-
F01-F99chapter
Excludes2
  • symptoms, signs and abnormal clinical laboratory findings, not elsewhere classified (R00-R99)R00-R99

Excludes1 — never code together. The excluded condition and this one are mutually exclusive.

Excludes2 — not included here, but the patient may have both. Code both when documented.

Instructional notes 3
F18code
Includes
  • volatile solvents
F18.97code
Inclusion terms
  • Inhalant-induced major neurocognitive disorder
F01-F99chapter
Includes
  • disorders of psychological development
Index entries leading here 3
  • Dementia (degenerative (primary)) (persisting) (unspecified severity) (without behavioral disturbance, psychotic disturbance, mood disturbance, and anxiety) F03.90
  • Inhalant-induced
    • major neurocognitive disorder F18.97
  • Use (of)
Alongside this code 7 same parent — F18.9
Additional references
AHA Coding Clinic® Licence required

Official coding advice for this code. Published by the American Hospital Association. Not included in this installation.

Risk adjustment

CMS22HCC54 CMS28HCC135 ESRD21HCC54 ESRD24HCC54

Presence is a property of the code. Untick a model to hide it everywhere.

This code

Billable
yes
Code set
FY2026
Parent
F18.9
Block
F10-F19
Siblings
7

Present FY2024–FY2027.